Enhancement of Suboptimal CD8 Cytotoxic T Cell Effector Function In Vivo Using Antigen-Specific CD80 Defective T Cells

作者: Irina Puliaeva , Kateryna Soloviova , Maksym Puliaiev , Thomas Lang , Roman Puliaev

DOI: 10.4049/JIMMUNOL.0902370

关键词:

摘要: T cell upregulation of B7 molecules CD80 and CD86 limits expansion in immunodeficient hosts; however, the relative roles separate from on CD4 versus CD8 cells a normal immune system are not clear. To address this question, we used parent-into-F1 (P→F1) murine model graft-versus-host disease transferred optimal suboptimal doses and/or knockout (KO) into F1 hosts. Enhanced elimination host B by KO was observed only at donor greatest for KO→F1 mice. Wild-type exhibited peak day 10; greater (day 10) proliferation effector CTL numbers wild-type→F1 Fas or programmed death-1 as homeostatic contraction days 12-14. Mixing studies demonstrated that maximal seen when both were deficient. These results indicate an important role Ag-activated limiting effectors part response. Our support further therapeutic targeting conditions characterized responses.

参考文章(40)
Alan J. Korman, Karl S. Peggs, James P. Allison, Checkpoint blockade in cancer immunotherapy Advances in Immunology. ,vol. 90, pp. 297- 339 ,(2006) , 10.1016/S0065-2776(06)90008-X
Keith B. Elkon, Andrei Shustov, Fred Finkelman, Charles S. Via, Phuong Nguyen, Differential expression of Fas and Fas ligand in acute and chronic graft-versus-host disease: up-regulation of Fas and Fas ligand requires CD8+ T cell activation and IFN-gamma production. Journal of Immunology. ,vol. 161, pp. 2848- 2855 ,(1998)
Thomas J. Lang, Phuong Nguyen, Robert Peach, William C. Gause, Charles S. Via, In Vivo CD86 Blockade Inhibits CD4+ T Cell Activation, Whereas CD80 Blockade Potentiates CD8+ T Cell Activation and CTL Effector Function Journal of Immunology. ,vol. 168, pp. 3786- 3792 ,(2002) , 10.4049/JIMMUNOL.168.8.3786
William Gause, Peter Linsley, Charles S. Via, Phuong Nguyen, Violetta Rus, Differential effect of CTLA4Ig on murine graft-versus-host disease (GVHD) development: CTLA4Ig prevents both acute and chronic GVHD development but reverses only chronic GVHD. Journal of Immunology. ,vol. 157, pp. 4258- 4267 ,(1996)
Zohreh Tatari-Calderone, Roshanak Tolouei Semnani, Thomas B. Nutman, Jeffrey Schlom, Helen Sabzevari, Acquisition of CD80 by Human T Cells at Early Stages of Activation: Functional Involvement of CD80 Acquisition in T Cell to T Cell Interaction Journal of Immunology. ,vol. 169, pp. 6162- 6169 ,(2002) , 10.4049/JIMMUNOL.169.11.6162
Angela Panoskaltsis-Mortari, Bruce R. Blazar, Robert Korngold, Daniel A. Vallera, Patricia A. Taylor, Arlene H. Sharpe, Gary S. Gray, Infusion of anti-B7.1 (CD80) and anti-B7.2 (CD86) monoclonal antibodies inhibits murine graft-versus-host disease lethality in part via direct effects on CD4+ and CD8+ T cells. Journal of Immunology. ,vol. 157, pp. 3250- 3259 ,(1996)
Alfonso Martín-Fontecha, Monica Moro, Maria Cristina Crosti, Fabrizio Veglia, Giulia Casorati, Paolo Dellabona, Vaccination with Mouse Mammary Adenocarcinoma Cells Coexpressing B7-1 (CD80) and B7-2 (CD86) Discloses the Dominant Effect of B7-1 in the Induction of Antitumor Immunity The Journal of Immunology. ,vol. 164, pp. 698- 704 ,(2000) , 10.4049/JIMMUNOL.164.2.698
R A Eisenberg, P L Cohen, J P Weintraub, UP-REGULATION OF FAS AND THE COSTIMULATORY MOLECULES B7-1 AND B7-2 ON PERIPHERAL LYMPHOCYTES IN AUTOIMMUNE B6/GLD MICE Journal of Immunology. ,vol. 159, pp. 4117- 4126 ,(1997)
Roman Puliaev, Irina Puliaeva, Lisbeth A. Welniak, Abigail E. Ryan, Mark Haas, William J. Murphy, Charles S. Via, CTL-Promoting Effects of CD40 Stimulation Outweigh B Cell-Stimulatory Effects Resulting in B Cell Elimination and Disease Improvement in a Murine Model of Lupus Journal of Immunology. ,vol. 181, pp. 47- 61 ,(2008) , 10.4049/JIMMUNOL.181.1.47